Ayurcann Holdings Corp. (CSE:AYUR)

Revenue by Segment

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Pharmaceuticals	31.11M	25.16M	12.49M	9.39M	7.63M
Total	31.11M	25.16M	12.49M	9.39M	7.63M

Revenue by Geography

Financials in millions CAD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Canada	31.11M	25.16M	12.49M	9.39M	7.63M
Total	31.11M	25.16M	12.49M	9.39M	7.63M

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error